Anvesana

New York, United States

Anvesana develops therapies for treating inheritable blood and bleeding disorders.

$250K raised

Sep 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Anvesana raised?

Anvesana has raised $250K in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are Anvesana's investors?

Anvesana's investors include Pathway to Cures.

Where is Anvesana headquartered?

Anvesana is headquartered in New York, United States.

What does Anvesana do?

Anvesana develops therapies for treating inheritable blood and bleeding disorders.

What stage is Anvesana at?

Anvesana is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 5, 2023.

MLA

"Anvesana — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/anvesana. Accessed July 2, 2026.

APA

VCBacked. (2023). Anvesana — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/anvesana

Wikipedia (cite web)

{{cite web |title=Anvesana — Funding & Investors |url=https://www.vcbacked.co/company/anvesana |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 5, 2023.